The value of molecular imaging for prostate cancer
Molecular imaging without compromise
Prostate cancer facts and figures
Facts to consider
- 2nd most common cancer after skin cancer1
- There was an estimated >3.2 million American men living with the disease, in 20091
Incidence
- Median age at diagnosis is 672 years old
- 1 in 8 men will be diagnosed with prostate cancer globally during his lifetime2
Morbidity
- 32.3% five-year relative survival rate for patients with distant metastasis1
- 1 in 41 will succumb to prostate cancer1
Theranostics: Personalized care for prostate cancer
Clinical case studies
Education
More information
By clicking Submit you consent to the processing of your above given personal data by the Siemens Healthineers company referred to under Corporate Information and for the purpose described above. Further information concerning the processing of your data can be found in the Data Privacy Policy. You are aware that you can partially or completely revoke this consent at any time for the future. Please declare your revocation to the contact address given in the Corporate Information and sent it to us via the following e-mail address: dataprivacy.func@siemens-healthineers.com.
Need more information...
Did this information help you?
1
https://seer.cancer.gov/statfacts/html/prost.html
2
https://www.wcrf.org/cancer-trends/prostate-cancer-statistics/
The outcomes achieved by the Siemens Healthineers customers described herein were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (eg, hospital size, case mix, level of IT adoption) there can be no guarantee that others will achieve the same results.
Header image data courtesy of 210 PET Imaging, Cary, North Carolina, USA.
